We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
129 result(s) found, displaying 76 to 100
-
Market actionsSun Herbal Pty Ltd is recalling Clear the Skin Formula a.k.a. Liang Xue Xiao Feng San CM116, a Chinese medicine for skin rash because the label does not display the required warning statement.
-
Safety alertsRead our safety advisory for Medicines containing Withania somnifera (Withania, Ashwagandha). Be aware of potential gastrointestinal symptoms and very rare cases of liver injury.
-
Safety alertsBullblood tablets pose a serious risk to your health and should not be taken.
-
Safety alertsExcite for her tablets pose a serious risk to your health and should not be taken.
-
Safety alertsKamasutra herbal jelly for him bottle poses a serious risk to your health and should not be taken.
-
Safety alertsTantra Jelly oral jelly satchels pose a serious risk to your health and should not be taken.
-
Safety alertsKamasutra Herbal Jelly for him oral jelly sachets pose a serious risk to your health and should not be taken.
-
Safety alertsThrob Herbal supplement tablets pose a serious risk to your health and should not be taken.
-
Market actionsIf you have an implanted SMR MB L1 Liner you may be at higher risk of requiring revision surgery.
-
Market actionsSub Herbal is recalling all batches supplied in Australia of Liu Wei Di Huang Wan (Rehmannia Six Formula) supplements as a precaution. There is potential for the medicine to result in unacceptable amounts of lead.
-
Market actionsMedtronic Australasia Pty Ltd is alerting patients who have an implanted SynchroMed II Pump that it may not function properly after they undergo a Magnetic Resonance Imaging (MRI) procedure.
-
Market actionsWe're continuing to investigate and take action on the potential contamination of some saline products with Ralstonia pickettii. Read about the latest round of product recalls.
-
Market actionsTesting indicates the presence of Ralstonia pickettii in additional saline products manufactured at Legency Remedies Private. All batches of these products are now being recalled from the Australian market.
-
Market actionsKin Fertility Pty Ltd is recalling several batches of The Prenatal capsules due to reported quality problems with the capsules. There is no indication of any safety concerns.
-
Safety alertsYing Da Wang tablets pose a serious risk to your health and should not be taken. They contain the undeclared substance sildenafil, which may interact with some prescription drugs. This may lower your blood pressure to dangerous levels.
-
Safety alertsBigger Longer More Time More Sperms capsules pose a serious risk to your health and should not be taken. They contain the undeclared substance sildenafil, which may interact with some prescription drugs. This may lower your blood pressure to dangerous levels.
-
Safety alertsLi Da Daidaihua capsules pose a serious risk to your health and should not be taken. They contain the undeclared substance sibutramine. This increases the risk of cardiac events and stroke.
-
Safety alertsBAIWEI Maximum Powerful tablets pose a serious risk to your health and should not be taken. They contain the undeclared substance sildenafil, which may interact with some prescription drugs. This may lower your blood pressure to dangerous levels.
-
Safety alertsThere are new warnings about the risks of heart attack and stroke with taking romosozumab (Evenity). The Product Information (PI) and Consumer Medicine Information (CMI) have been updated to reflect these risks.
-
Safety alertsOur safety advisory includes information for consumers and health professionals about low levels of nitrosamine impurity in medicines containing sitagliptin.
-
Market actionsWe're continuing to monitor adverse events from masks that have magnets interacting with implantable medical devices. Find out how we're working with companies supplying these devices in Australia and international regulators.
-
Market actionsInterpharma Pty Ltd is recalling all batches of Sodium Chloride 0.9% 30mL ampoules due to potential contamination with Ralstonia pickettii. You can return them for a refund.
-
Market actionsWe're continuing to investigate and take action about the potential contamination of some saline products with Ralstonia pickettii. Read about a product recall and quarantines.
-
Market actionsWe're aware of Ralstonia pickettii cases in patients across Australia and are working closely with health departments to investigate the possible role of therapeutic goods.
-
Market actionsIf you've purchased APOHEALTH Paracetamol Pain Relief paracetamol 500 mg film-coated tablets in a bottle, ensure it is kept out of reach of children. This product does not have child-resistant packaging.